.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Adam Brufsky, MD

EP. 1: Neratinib in the Adjuvant Setting The Paradigm Shift for HER2+ Breast Cancer Neratinib Toxicity Management

February 7th 2017

EP. 2: Neratinib for Metastatic Breast Cancer

February 7th 2017

EP. 3: Personal Experience with Neratinib

February 7th 2017

EP. 4: CDK4/6 Inhibitors for HR+ Breast Cancer; Emergence of Ribociclib

February 7th 2017

EP. 5: Sequencing Therapies for HR+ Metastatic Breast Cancer

February 7th 2017